Simple Steps to Help Prevent Metastatic Tumors
STORY AT-A-GLANCE Editor's Note: This article is a reprint.
It was originally published May 9, 2021. In this interview, Susan Wadia-Ells, Ph.D., discusses breast cancer as an unnecessary U.S. epidemic and how to help prevent it, which is the topic of her book, " Busting Breast Cancer: Five Simple Steps to Keep Breast Cancer Out of Your Body ." This year alone, an expected 300,000 women in the U.S. will be diagnosed with invasive breast cancer.
Another 50,000 are projected to be diagnosed with non-invasive breast cancer, which in all likelihood isn't cancer at all. Wadia-Ells has a graduate degree in energy economics and political development (MALD) and a Ph.D. in women's studies with a focus on women's autobiographical writing. "This really means that I am an investigative reporter," she says, "and so I've come to this with a very innocent, independent mind." The inspiration behind the book was Wadia-Ells' experience of losing several friends to recurrent metastatic breast cancer, meaning cancer that was "successfully treated" at an early stage, only to later return as a terminal stage or metastatic disease.
"Between 20% and 40% of women who have been "successfully treated" in theUnited States today will end up with recurrent metastatic breast cancer, whichmeans an early death sentence for most women,"
"And I just got very angry. I love to investigate new topics. I've always been achange-maker throughout my whole career. I've just followed and done what Iwanted to do. And this, I just fell into it and wouldn't let it go."
Breast Cancer Treatment Is a For-Profit Industry
The for-profit cancer industry makes a fortune overdiagnosing breast cancer cases and then treating women with infiammatory and toxic remedies that increase your risk of developing real cancer. So, overall, the financial component is a motivating catalyst in the U.S. for much of what we're seeing within the breast cancer industry, including that so-called "Breast Cancer Awareness," month that can be translated as: "Get Your Mammogram Month."
"The reason I wanted to do this book was really to teach women how to avoidgetting breast cancer. Once you have a mammogram, you can sometimes endup being unnecessarily diagnosed and treated. And then that becomesincredibly expensive and harmful.As I said, 20% to 40% of women who are being diagnosed and treated for anearly stage breast cancer end up being treated for recurrent metastatic breastcancer, which means they're spending an inordinate amount of money. Thesemetastatic drugs that have been developed are not even meant to stop thedisease; they have been developed to extend your life by a matter of months …[The reason] why it's so important for women to read the book and understandthe five simple steps in Busting Breast Cancer is because most of these stepsgo against everything that the American Cancer Society is telling us, that SusanG. Komen is telling us, that in most cases, our regular primary care practitionersare telling us. And women have a much harder time questioning authority thanmen.And so, as breast cancer has now become this epidemic that surrounds us …women have got to learn how to look at the facts, learn to be brave and questionauthority, and ‘take risks' by going against these authorities. From early ages,women are much more terrified of going against authority.And in order to protect ourselves and knock down the risk of breast cancer by80% or more, it means a woman is going to have to stand up to the AmericanCancer Society and say, ‘Yes, I'm going to have a clinical breast exam. Yes, I'mgoing to do breast self-exams again. No, I don't want a mammogram' — all ofthese things that go against what women are being taught right now by thecancer industry."
I've done extensive articles on mammography in the past, so much so that the State of Illinois Medical Board tried to remove my license, even though I wasn't selling anything related to breast cancer. I was just telling people about the dangers of mammograms and disputing a study published in The New England Journal of Medicine. I appealed and sued the medical board in the Illinois state supreme court and won, on grounds of first amendment freedom of speech, which is progressively being destroyed in real time in 2021. But that just goes to show the lengths to which the industry will go to protect the conventional narrative — a narrative that is ultimately harming more women than it's helping.
Cancer Is a Lifestyle Disease
As noted by Wadia-Ells, statistical studies reveal there are a number of lifestyle and environmental issues that raise a woman's breast cancer risk, including birth control drugs and vitamin D3 deficiency . Yet, the medical industry still has no answer as for why breast cancer occurs. They treat it like it's a mystery that no one knows anything about, which simply isn't true. In 2013, Wadia-Ells discovered Thomas Seyfried's book, "The Metabolic Theory of Cancer," which I have highlighted in many previous articles. Seyfried's theory on the origin of that first cancer cell allowed her to finally connect dozens of statistical studies on the risks of birth control drugs, progestin menopausal drugs, mammograms, biopsies, environmental toxins and more. She was finally able, for the first time, to develop a clear set of biologically-based effective breast cancer prevention strategies for individual women. "Women need to understand that we can prevent this disease, probably 80%, if not more, of the time," she says. Lifestyle variables reviewed in Wadia-Ells' book include the danger of chemical progestin drugs, toxic/unbalanced levels of estrogen from excess body fat, and high cortisol levels from chronic long-term stress. These are all significant assaults that contribute to the suffocation of breast cells' mitochondria. This suffocation is the first step in the creation of that first cancer cell. Processed foods are another culprit that need to be avoided, foods high in refined and hydrogenated vegetable oils in particular, as they are loaded with an omega-6 fat called linoleic acid (LA). Minimizing LA to pre-1850 levels, or 1% to 2% of your total daily calorie intake, which is 90% to 95% lower than what the average American consumes, is crucial. I believe it's probably the most significant metabolic poison in our diet.
Prevention Begins With Shedding Excess Body Fat
Topping Wadia-Ells' list of prevention strategies is shedding excess body fat by following a low-carb or ketogenic lifestyle . This type of daily eating helps lower the production of excess or unbalanced estrogen from fat cells, which reduces long term mitochondrial damage. Unknown to many, excess body fat creates an enzyme called aromatase; an enzyme required in the production of natural estrogen. You need to be careful about the types of fat you eat, however. Going on a low carb/high-fat diet, will help only, if you limit your intake of toxic omega-6 fat (linoleic acid) to less than 5% of total calorie intake.
"That takes us back to Seyfried's metabolic theory of cancer. We nowunderstand that what causes that first cancer cell to happen — be that a breastcancer cell or a brain cancer cell — is assaults on the [mitochondria], the powerbatteries within your cells … that basically suffocate them.So all of these things are suffocating the mitochondria, and when you haveunbalanced estrogen to progesterone, or the chemical progestin, these are alltoxic conditions that suffocate, that harm those mitochondria.In Chapter 4 in the book, I talk about the importance of not taking birth controldrugs or Prempro, a combination of menopausal relief drugs, or even having aprogestin-laced IUD inserted, because progestin has now been shown to notonly accelerate breast cancer, but it also has the potential of initiating breastcancer."
In short, excess or unbalanced estrogen will increase a woman's risk for breast cancer. That's why many who are diagnosed with breast cancer find they are not metabolizing or eliminating this processed or "used" estrogen eficiently, causing an imbalance. Wadia-Ells recommends getting a hormone balancing test to make sure your estrogen and progesterone levels are properly balanced and, if not, get an estrogen metabolite test done to see if you're eficiently eliminating this now-processed or excess estrogen. If your ability to eliminate your processed estrogen is sluggish, there are supplements and other strategies that can help boost your ability to eficiently eliminate your "used" estrogen, so you don't end up with toxic levels. Ideally, you'll want to measure all three types of natural estrogen your body can make: estrone, estradiol and estriol. The ratios among these three are also important.
The Dangers of Progestin
Progesterone is a helpful and important natural hormone. Progestin, a chemical that offers a few attributes of natural progesterone, however, can initiate and accelerate breast cancer. Intuitively, it makes sense that synthetic hormones might be more dangerous than naturally-occurring ones made by your body, and in fact they are. Wadia- Ells explains:
"In 2010, there was an incredibly important study that has gotten buried. Thelead researcher was Josef Penninger. On that international study team of about12 people, one is now the CEO and president of Dana-Farber Cancer Institute.The researchers spent 10 years working with mice in preclinical settings, tryingto figure out why women who take progestin-based drugs — be they birthcontrol drugs or menopausal drugs — have anywhere from a 26% to an eightfoldincreased risk of developing breast cancer.They finally published a study in 2010 that basically explained, in some moredetail, but not totally, how the progestin pulls out or activates something calledRANKL, which is a protein. The RANKL, apparently — though they don't saythese words — can suffocate the mitochondria in a woman's breast cell,initiating that first cancer cell.The sad thing is that no researchers in the field of breast cancer prevention evercite this study. They're not aware of it for some reason. But, it was published inOctober of 2010 in Nature magazine, which we all know is a very significant,well-known scientific journal."
Tragically, the medical and scientific professions continue to confiate the terms "progestin," and "progesterone," ignoring the fact that these substances are not the same. Chemically, they are very different. So, when reading studies, you have no way of knowing whether a researcher is talking about progestin, the chemical that causes and accelerates breast cancer, or natural progesterone, which when balanced with natural estrogen, does not cause a problem. In fact, natural progesterone appears to work as a tumor suppressor. It's even used in men with prostate cancer, with significant success.
Proper Administration of Hormones
The delivery system of estrogen and/or progesterone is a third issue that plays a role. The worst delivery method is oral delivery, as the hormone must go through your digestive system and liver before it reaches your bloodstream. Transdermal application is also problematic because, over time, your body becomes increasingly resistant to it as it builds up in your cells. The most ideal delivery method is transmucosally, where you apply the cream or suppository either into your vagina or rectum. This will bypass liver metabolism and get the hormone directly into your blood.
The Importance of Vitamin D3
Vitamin D3 is another crucial factor for cancer prevention . As noted by Wadia-Ells, studies show a vitamin D3 level of 40 ng/mL is protective against prostate and liver cancer, but for breast cancer, you need a level of at least 60 ng/mL (100 nmol/L). "That 60 ng/mL becomes the magical number when a woman is trying to protect herself from developing breast cancer," she says. Indeed, several studies suggest vitamin D optimization alone can knock your breast cancer risk down by about 80%. Sensible sun exposure is the best way to optimize your level, but for a vast majority of people, a supplement is typically required to reach and maintain a level between 60 ng/mL and 80 ng/mL (100 nmol/L to 150 nmol/L) year-round. Latitude tends to be a limiting factor because most people in the U.S. are unable to get significant vitamin D from the sun between September and May. Even in the middle of summer, you have to spend time outside in a bathing suit, not fully clothed, in order for it to work. Regardless of how you're getting your vitamin D3, the key is to test your level once or twice a year. This is the only way to ensure that what you're doing is providing you with the vitamin D you need for optimal health and disease prevention. If you don't know your D3 blood level, you have no way of knowing whether your immune system is strong enough to protect you from any fast-growing developing breast cancer cells or not. Keep in mind that if you are obese, your body will store about half the vitamin D3 you ingest in your fat cells, which means you'll need higher doses than someone of normal weight.
"If you take 5,000 IUs of D3 a day, it could be that your body is only able toutilize half of that. The other half is being stored in your fat cells. What somefunctional medicine physicians are finding is that when women or men start tolose weight, once they lose 15% of their weight, the fat cells let loose the storedD3 and their D3 blood level goes shooting up,"
Many Breast Cancer Cases Really Aren't Breast Cancer
As mentioned earlier, mammograms can get you into trouble. "One simple mammogram can really take you down a bad path," Wadia-Ells says. First of all, you're compressing your breast tissue, which in itself can cause tissue damage, and if you do have a tumor, that tumor could potentially be broken apart, resulting in metastatic breast cancer.
Ductal carcinoma in situ or DCIS is not actually atumor. It's not invasive. It's not cancer. Studiessuggest only about 5% of DCIS will eventually, a decadeor more down the line, turn into cancer.
"But probably the major concern that I have with mammograms is the fact that they are the only way the cancer industry can diagnose if a woman has atypical cells or a tiny indolent tumor that may never grow," Wadia-Ells says. The term "atypical cells" later became known as ductal carcinoma in situ or DCIS — a far more frightening term than "atypical cells." Fear sells, and this is true in the cancer industry as well. DCIS is not actually a tumor. It's not invasive. It's not cancer. Studies suggest only about 5% of DCIS will eventually, a decade or more down the line, turn into cancer. Yet DCIS has now been renamed yet again as "Stage 0 breast cancer."
"I have met so many women and they go, ‘I had breast cancer, but happily, theyfound it early. I'm fine.' And I say to them, ‘What stage was it?' Sometimes theydon't know, but if they do know, they might say, ‘Stage Zero,' and the first thing Iwant to say to them is, ‘You did not have breast cancer. You never had breastcancer.'But the problem is they were treated as if they had breast cancer. So, a biopsy,often using fine needle aspiration, was done, which infiames the tissue, whichcan then create cancer. Sometimes they had surgery. I've met women who havehad double mastectomies because they had DCIS. It's a travesty.People are being given all of these reasons to be fearful about breast cancer.My book becomes a unique piece of merchandise in the store, because it'ssaying, ‘No, you don't have to fear it anymore. There are ways that you can stopit before it starts.' And with recurrent metastatic breast cancer, there actuallyare ways that are nontoxic, that can literally make metastatic cells go away.And there's even a case study from Turkey in my book of how they have usedstrictly nontoxic metabolic therapies to remove all of the metastatic cells fromthis 30-year-old woman. And as long as she was willing to participate and stayon her low-carb diet and have her non-toxic therapies every few months, shestayed clear."
Why Biopsies Are a Bad Idea
As mentioned earlier, 20% to 40% of women treated for early stage breast cancer in the U.S. go on to develop recurrent metastatic breast cancer. The question is, what percentage of those cases were actually caused by diagnostics and/or treatment?
"Dr. Seyfried clearly describes … in his book, ‘Cancer as a Metabolic Disease,'the biological process. When a tumor cell is released from a biopsy and theinfiammation is happening, the immune system cells, including macrophages,come in to try and heal this new wound that the surgeon has just created in thewoman's breast.That macrophage can then morph into a hybrid cell; merged with that errantbreast cancer cell, it can take off into the woman's body. In the majority ofwomen who end up with metastatic breast cancer, it goes either to the bone, tothe brain or to the liver, and maybe one other spot. It's very clear that there's ametabolic process involved. It's not a haphazard process.What I'm trying to do, and I talk about this in Chapter 10, is get the state cancerboards to release the annual data they have on recurrent metastatic breastcancer. The state cancer boards are required to collect that data within sixmonths of a diagnosis from licensed physicians and from licensed cancerclinics.But the state cancer boards, to the best of my knowledge, are not allowed torelease that data. I feel the recurrent metastatic breast cancer epidemic isgrowing exponentially. You can see this by looking at data from clinical studiesand from the exponential growth of income coming from metastatic breastcancer drugs. More than 50% of all the income in the breast cancer industrytoday is metastatic breast cancer drug income."
Certain Drugs Impact Your Breast Cancer Risk
In her book, Wadia-Ells also details the risks of certain popular drugs. Women who have been on a statin drug for more than 10 years, for example, have been shown to double their risk of breast cancer. This is a drug that 1 in 4 American adults over the age of 40 is on, so it's a significant issue. Another group of common but hazardous drugs are progestin-based birth control drugs and IUDs or intrauterine devices laced with progestin. A far safer alternative is the hormone-free copper coil IUD. However, today, FDA regulations have created a single monopoly-priced, hormone-free IUD, much too expensive for women who do not have health insurance. While the actual cost of this tiny and simple device is about 50 cents in the U.S., women or their insurance must pay more than $800 to purchase and have the IUD inserted. Wadia-Ells explains:
"This is where my graduate work in political economy came in, so it served mewell. I just kept unpeeling the onion. In the '70s, we had a variety of types andsizes of hormone-free IUDs. They didn't have progestin-based IUDs back then.By 1999, there was suddenly only one IUD on the U.S. market, and that wastoday's copper coil IUD named Paragard.Suddenly, overnight, the FDA decided to reclassify this 50-cent copper coil froma medical device — what it had been for 30 years — to a pharmaceutical drug.They said that the copper causes the effectiveness of the IUD; therefore, it's adrug.When they did that, they virtually blocked the market for all other hormone-freeIUDs, because … now that hormone-free IUDs were considered to be drugs, andthey had remained effective for 10 years, companies had to do multimillion-dollar, 10-year, double-blind, placebo-controlled studies for any IUD, i.e., "drug."So, many women in the U.S. have developed breast cancer because they'vebeen forced to go on the birth control drug because the cost of that hormone-free IUD became unbearable. Low-income women were given, and still are beinggiven, the progestin-only contraceptive shots that last for three months, whichincrease their risk of breast cancer worse than if they're taking the pill.These drugs are increasing one's breast cancer risk much more than if a womanis on a hormone-free IUD, because she is not getting that progestin. I believethat this IUD reclassification in 1999 was done to support the birth control drugindustry."
What's more, why did no one insist on studying birth control drugs once it was discovered, in 2002, that post-menopausal women using the progestin-based menopausal drug, increased their risk of developing palpable tumors by 26% within three years? After all, contraceptive drugs can have 10 times more progestin than menopausal progestin drugs.
"They didn't do it, I am sure, because the industry did not want to destroy theirbirth control drug revenues,"
. "And so, there's a reason we haveseen premenopausal women's breast cancer rates increase in the United States.In my book I show the study that my little group did. We contacted several statecancer boards and said, ‘Can you send us the rate of breast cancer of womenunder 50 years old between 1985 — when they started to advertise birth controldrugs on TV — and 2005?'And we saw, no matter if it were Florida, Colorado or Massachusetts — thosewere the three states we ended up looking at — there was a 1% to 2% annualincrease over those years in breast cancer rates in women under 50.That's when birth control drugs really had taken off, because the Clintonadministration allowed these drug ads to be put on television, so you could tellyour doctor what drug you wanted, instead of having the doctor tell you whatdrug you should have.There are seven political action steps in my book, and one of them is forwomen's groups and health groups to go to the FDA and knock on the door andsay, 'Change it back. Make the hormone-free IUD a medical device again, andopen up the market, fiood the market with all of these affordable Europeanmakes and models.'"
Read the full article at the original website